• OPEN AN ACCOUNT
Indian Indices
Nifty
24,768.35 -86.70
(-0.35%)
Sensex
81,185.58 -296.28
( -0.36%)
Bank Nifty
55,961.95 -188.75
( -0.34%)
Nifty IT
35,301.65 -180.05
( -0.51%)
Global Indices
Nasdaq
44,167.41 -314.88
(-0.71%)
Dow Jones
6,364.11 -19.79
(-0.31%)
Hang Seng
41,114.76 460.06
(1.13%)
Nikkei 225
9,132.81 -4.13
(-0.05%)
Forex
USD-INR
86.92 0.29
(0.33%)
EUR-INR
100.47 -0.57
(-0.57%)
GBP-INR
115.97 -0.14
(-0.12%)
JPY-INR
0.59 0.00
(0.14%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
345.7618998
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
15.39
106062.83
EPS(TTM)
Face Value()
Div & Yield %
82.6
1
0.63
 

Genus Prime Infra reports consolidated net loss of Rs 0.02 crore in the March 2025 quarter
May 30,2025
Net loss of Genus Prime Infra reported to Rs 0.02 crore in the quarter ended March 2025. There were no net profit/loss reported during the previous quarter ended March 2024. Sales declined 33.33% to Rs 0.02 crore in the quarter ended March 2025 as against Rs 0.03 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.04 crore in the year ended March 2025 as against net loss of Rs 2.00 crore during the previous year ended March 2024. Sales declined 4.35% to Rs 0.22 crore in the year ended March 2025 as against Rs 0.23 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales0.020.03 -33 0.220.23 -4
OPM %-100.000 --18.18-869.57 -
PBDT-0.020 0 -0.04-2.00 98
PBT-0.020 0 -0.04-2.00 98
NP-0.020 0 -0.04-2.00 98